<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Am J Hum Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">Am. J. Hum. Genet</journal-id>
      <journal-title-group>
        <journal-title>American Journal of Human Genetics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0002-9297</issn>
      <issn pub-type="epub">1537-6605</issn>
      <publisher>
        <publisher-name>Elsevier</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">30929742</article-id>
      <article-id pub-id-type="pmc">6451933</article-id>
      <article-id pub-id-type="publisher-id">S0002-9297(19)30061-8</article-id>
      <article-id pub-id-type="doi">10.1016/j.ajhg.2019.02.016</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Mutations in the Neuronal Vesicular SNARE <italic>VAMP2</italic> Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Salpietro</surname>
            <given-names>Vincenzo</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="aff3" ref-type="aff">3</xref>
          <xref rid="fn1" ref-type="fn">24</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Malintan</surname>
            <given-names>Nancy T.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
          <xref rid="fn1" ref-type="fn">24</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Llano-Rivas</surname>
            <given-names>Isabel</given-names>
          </name>
          <xref rid="aff5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Spaeth</surname>
            <given-names>Christine G.</given-names>
          </name>
          <xref rid="aff6" ref-type="aff">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Efthymiou</surname>
            <given-names>Stephanie</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Striano</surname>
            <given-names>Pasquale</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vandrovcova</surname>
            <given-names>Jana</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cutrupi</surname>
            <given-names>Maria C.</given-names>
          </name>
          <xref rid="aff7" ref-type="aff">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chimenz</surname>
            <given-names>Roberto</given-names>
          </name>
          <xref rid="aff7" ref-type="aff">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>David</surname>
            <given-names>Emanuele</given-names>
          </name>
          <xref rid="aff8" ref-type="aff">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Di Rosa</surname>
            <given-names>Gabriella</given-names>
          </name>
          <xref rid="aff9" ref-type="aff">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marce-Grau</surname>
            <given-names>Anna</given-names>
          </name>
          <xref rid="aff10" ref-type="aff">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Raspall-Chaure</surname>
            <given-names>Miquel</given-names>
          </name>
          <xref rid="aff10" ref-type="aff">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Martin-Hernandez</surname>
            <given-names>Elena</given-names>
          </name>
          <xref rid="aff11" ref-type="aff">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zara</surname>
            <given-names>Federico</given-names>
          </name>
          <xref rid="aff12" ref-type="aff">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Minetti</surname>
            <given-names>Carlo</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <collab>Deciphering Developmental Disorders Study</collab>
        </contrib>
        <contrib contrib-type="author">
          <collab>SYNAPS Study Group<contrib-group><contrib contrib-type="author"><name><surname>Salpietro</surname><given-names>Vincenzo</given-names></name></contrib><contrib contrib-type="author"><name><surname>Efthymiou</surname><given-names>Stephanie</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kriouile</surname><given-names>Yamna</given-names></name></contrib><contrib contrib-type="author"><name><surname>El Khorassani</surname><given-names>Mohamed</given-names></name></contrib><contrib contrib-type="author"><name><surname>Aguennouz</surname><given-names>Mhammed</given-names></name></contrib><contrib contrib-type="author"><name><surname>Karashova</surname><given-names>Blagovesta</given-names></name></contrib><contrib contrib-type="author"><name><surname>Avdjieva</surname><given-names>Daniela</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kathom</surname><given-names>Hadil</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tincheva</surname><given-names>Radka</given-names></name></contrib><contrib contrib-type="author"><name><surname>Van Maldergem</surname><given-names>Lionel</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nachbauer</surname><given-names>Wolfgang</given-names></name></contrib><contrib contrib-type="author"><name><surname>Boesch</surname><given-names>Sylvia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Arning</surname><given-names>Larissa</given-names></name></contrib><contrib contrib-type="author"><name><surname>Timmann</surname><given-names>Dagmar</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cormand</surname><given-names>Bru</given-names></name></contrib><contrib contrib-type="author"><name><surname>P&#xE9;rez-Due&#xF1;as</surname><given-names>Belen</given-names></name></contrib><contrib contrib-type="author"><name><surname>Di Rosa</surname><given-names>Gabriella</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pironti</surname><given-names>Erica</given-names></name></contrib><contrib contrib-type="author"><name><surname>Goraya</surname><given-names>Jatinder S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sultan</surname><given-names>Tipu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kirmani</surname><given-names>Salman</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ibrahim</surname><given-names>Shahnaz</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jan</surname><given-names>Farida</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mine</surname><given-names>Jun</given-names></name></contrib><contrib contrib-type="author"><name><surname>Banu</surname><given-names>Selina</given-names></name></contrib><contrib contrib-type="author"><name><surname>Veggiotti</surname><given-names>Pierangelo</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ferrari</surname><given-names>Michel D.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Verrotti</surname><given-names>Alberto</given-names></name></contrib><contrib contrib-type="author"><name><surname>Marseglia</surname><given-names>Gian Luigi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Savasta</surname><given-names>Salvatore</given-names></name></contrib><contrib contrib-type="author"><name><surname>Garavaglia</surname><given-names>Barbara</given-names></name></contrib><contrib contrib-type="author"><name><surname>Scuderi</surname><given-names>Carmela</given-names></name></contrib><contrib contrib-type="author"><name><surname>Borgione</surname><given-names>Eugenia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dipasquale</surname><given-names>Valeria</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cutrupi</surname><given-names>Maria Concetta</given-names></name></contrib><contrib contrib-type="author"><name><surname>Portaro</surname><given-names>Simona</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sanchez</surname><given-names>Benigno Monteagudo</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pineda-Marfa&#x2019;</surname><given-names>Mercedes</given-names></name></contrib><contrib contrib-type="author"><name><surname>Munell</surname><given-names>Francina</given-names></name></contrib><contrib contrib-type="author"><name><surname>Macaya</surname><given-names>Alfons</given-names></name></contrib><contrib contrib-type="author"><name><surname>Boles</surname><given-names>Richard</given-names></name></contrib><contrib contrib-type="author"><name><surname>Heimer</surname><given-names>Gali</given-names></name></contrib><contrib contrib-type="author"><name><surname>Papacostas</surname><given-names>Savvas</given-names></name></contrib><contrib contrib-type="author"><name><surname>Manole</surname><given-names>Andreea</given-names></name></contrib><contrib contrib-type="author"><name><surname>Malintan</surname><given-names>Nancy</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zanetti</surname><given-names>Maria Natalia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hanna</surname><given-names>Michael G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rothman</surname><given-names>James E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kullmann</surname><given-names>Dimitri M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Houlden</surname><given-names>Henry</given-names></name></contrib></contrib-group></collab>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bello</surname>
            <given-names>Oscar D.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>De Zorzi</surname>
            <given-names>Rita</given-names>
          </name>
          <xref rid="aff13" ref-type="aff">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fortuna</surname>
            <given-names>Sara</given-names>
          </name>
          <xref rid="aff14" ref-type="aff">14</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dauber</surname>
            <given-names>Andrew</given-names>
          </name>
          <xref rid="aff15" ref-type="aff">15</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alkhawaja</surname>
            <given-names>Mariam</given-names>
          </name>
          <xref rid="aff16" ref-type="aff">16</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sultan</surname>
            <given-names>Tipu</given-names>
          </name>
          <xref rid="aff17" ref-type="aff">17</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mankad</surname>
            <given-names>Kshitij</given-names>
          </name>
          <xref rid="aff18" ref-type="aff">18</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Vitobello</surname>
            <given-names>Antonio</given-names>
          </name>
          <xref rid="aff19" ref-type="aff">19</xref>
          <xref rid="aff20" ref-type="aff">20</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Thomas</surname>
            <given-names>Quentin</given-names>
          </name>
          <xref rid="aff20" ref-type="aff">20</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mau-Them</surname>
            <given-names>Frederic Tran</given-names>
          </name>
          <xref rid="aff19" ref-type="aff">19</xref>
          <xref rid="aff20" ref-type="aff">20</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Faivre</surname>
            <given-names>Laurence</given-names>
          </name>
          <xref rid="aff20" ref-type="aff">20</xref>
          <xref rid="aff21" ref-type="aff">21</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Martinez-Azorin</surname>
            <given-names>Francisco</given-names>
          </name>
          <xref rid="aff22" ref-type="aff">22</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Prada</surname>
            <given-names>Carlos E.</given-names>
          </name>
          <xref rid="aff6" ref-type="aff">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Macaya</surname>
            <given-names>Alfons</given-names>
          </name>
          <xref rid="aff10" ref-type="aff">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kullmann</surname>
            <given-names>Dimitri M.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rothman</surname>
            <given-names>James E.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
          <xref rid="aff23" ref-type="aff">23</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Krishnakumar</surname>
            <given-names>Shyam S.</given-names>
          </name>
          <email>s.krishnakumar@ucl.ac.uk</email>
          <xref rid="aff4" ref-type="aff">4</xref>
          <xref rid="aff23" ref-type="aff">23</xref>
          <xref rid="cor1" ref-type="corresp">&#x2217;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Houlden</surname>
            <given-names>Henry</given-names>
          </name>
          <email>h.houlden@ucl.ac.uk</email>
          <xref rid="aff3" ref-type="aff">3</xref>
          <xref rid="cor2" ref-type="corresp">&#x2217;&#x2217;</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Pediatric Neurology and Muscular Diseases Unit, IRCCS Istituto Giannina Gaslini, Genoa 16147, Italy</aff>
      <aff id="aff2"><label>2</label>Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa 16132, Italy</aff>
      <aff id="aff3"><label>3</label>Department of Molecular Neuroscience, UCL Institute of Neurology, University College London, London WC1N 3BG, UK</aff>
      <aff id="aff4"><label>4</label>Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, University College London, London WC1N 3BG, UK</aff>
      <aff id="aff5"><label>5</label>Department of Medical Genetics, Hospital Universitario Cruces, Greater Bilbao 48903, Spain</aff>
      <aff id="aff6"><label>6</label>Division of Human Genetics, Department of Pediatrics, University of Cincinnati, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229-3026, USA</aff>
      <aff id="aff7"><label>7</label>Division of Human Genetics, Department of the Adult and Developmental Age Human Pathology, University of Messina, Messina 98125, Italy</aff>
      <aff id="aff8"><label>8</label>Papardo University Hospital, Viale Ferdinando Stagno d'Alcontres, Contrada Papardo, Messina 98158, Italy</aff>
      <aff id="aff9"><label>9</label>Division of Child Neurology and Psychiatry, Department of the Adult and Developmental Age Human Pathology, University of Messina, Messina 98125, Italy</aff>
      <aff id="aff10"><label>10</label>Department of Pediatric Neurology, University Hospital Vall d'Hebron, Barcelona 08035, Spain</aff>
      <aff id="aff11"><label>11</label>Unidad de Enfermedades Mitocondriales-Metab&#xF3;licas Hereditarias, Departamento de Pediatr&#xED;a, Hospital 12 de Octubre, Madrid 28041, Spain</aff>
      <aff id="aff12"><label>12</label>Laboratory of Neurogenetics and Neuroscience, G. Gaslini Institute, Genova 16147, Italy</aff>
      <aff id="aff13"><label>13</label>Center of Excellence in Biocrystallography, Department of Chemical and Pharmaceutical Sciences, University of Trieste, Trieste 34127, Italy</aff>
      <aff id="aff14"><label>14</label>Department of Chemical and Pharmaceutical Sciences, University of Trieste, Trieste 34127, Italy</aff>
      <aff id="aff15"><label>15</label>Division of Endocrinology, Cincinnati Center for Growth Disorders, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229-3026, USA</aff>
      <aff id="aff16"><label>16</label>Prince Hamzah Hospital, Ministry of Health, Amman 11181, Jordan</aff>
      <aff id="aff17"><label>17</label>Department of Pediatric Neurology, Institute of Child Health and The Children&#x2019;s Hospital Lahore, 381-D/2, Lahore 54600, Pakistan</aff>
      <aff id="aff18"><label>18</label>Department of Neuroradiology, Great Ormond Street Hospital for Children, London WC1N 3JH, UK</aff>
      <aff id="aff19"><label>19</label>Unit&#xE9; Fonctionnelle Innovation en Diagnostic Genomique des Maladies Rares, Center Hospitalier Universitaire Dijon Bourgogne, Dijon 21079, France</aff>
      <aff id="aff20"><label>20</label>Inserm, UMR 1231, Genetique des Anomalies du Development, Universit&#xE9; de Bourgogne, Dijon 21079, France</aff>
      <aff id="aff21"><label>21</label>Center de R&#xE9;f&#xE9;rence Anomalies du D&#xE9;veloppement et Syndromes Malformatifs, H&#xF4;pital d'Enfants, Dijon 21079, France</aff>
      <aff id="aff22"><label>22</label>Centro de Investigaci&#xF3;n Biom&#xE9;dica en Red de Enfermedades Raras (CIBERER), Instituto de Investigaci&#xF3;n Hospital 12 de Octubre (i+12), Madrid 28041, Spain</aff>
      <aff id="aff23"><label>23</label>Department of Cell Biology, Yale University School of Medicine, New Haven, CT 06520, USA</aff>
      <author-notes>
        <corresp id="cor1"><label>&#x2217;</label>Corresponding author <email>s.krishnakumar@ucl.ac.uk</email></corresp>
        <corresp id="cor2"><label>&#x2217;&#x2217;</label>Corresponding author <email>h.houlden@ucl.ac.uk</email></corresp>
        <fn id="fn1">
          <label>24</label>
          <p id="ntpara0010">These authors contributed equally</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>04</day>
        <month>4</month>
        <year>2019</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>3</month>
        <year>2019</year>
      </pub-date>
      <volume>104</volume>
      <issue>4</issue>
      <fpage>721</fpage>
      <lpage>730</lpage>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>10</month>
          <year>2018</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>2</month>
          <year>2019</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2019 The Authors</copyright-statement>
        <copyright-year>2019</copyright-year>
        <license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p>
        </license>
      </permissions>
      <abstract id="abs0010">
        <p><italic>VAMP2</italic> encodes the vesicular SNARE protein VAMP2 (also called synaptobrevin-2). Together with its partners syntaxin-1A and synaptosomal-associated protein 25 (SNAP25), VAMP2 mediates fusion of synaptic vesicles to release neurotransmitters. VAMP2 is essential for vesicular exocytosis and activity-dependent neurotransmitter release. Here, we report five heterozygous <italic>de novo</italic> mutations in <italic>VAMP2</italic> in unrelated individuals presenting with a neurodevelopmental disorder characterized by axial hypotonia (which had been present since birth), intellectual disability, and autistic features. In total, we identified two single-amino-acid deletions and three non-synonymous variants affecting conserved residues within the C terminus of the VAMP2 SNARE motif. Affected individuals carrying <italic>de novo</italic> non-synonymous variants involving the C-terminal region presented a more severe phenotype with additional neurological features, including central visual impairment, hyperkinetic movement disorder, and epilepsy or electroencephalography abnormalities. Reconstituted fusion involving a lipid-mixing assay indicated impairment in vesicle fusion as one of the possible associated disease mechanisms. The genetic synaptopathy caused by <italic>VAMP2 de novo</italic> mutations highlights the key roles of this gene in human brain development and function.</p>
      </abstract>
      <kwd-group id="kwrds0010">
        <title>Keywords</title>
        <kwd>SNARE</kwd>
        <kwd>vesicle fusion</kwd>
        <kwd>neuronal exocytosis</kwd>
        <kwd>VAMP2</kwd>
        <kwd>synaptobrevin</kwd>
        <kwd>neurodevelopmental disorders</kwd>
        <kwd>synaptopathy</kwd>
        <kwd>autism</kwd>
        <kwd>movement disorders</kwd>
        <kwd>epilepsy</kwd>
      </kwd-group>
    </article-meta>
    <notes>
      <p id="misc0010">Published: March 28, 2019</p>
    </notes>
  </front>
  <body>
    <sec id="sec1">
      <title>Main Text</title>
      <p id="p0010">Chemical synaptic transmission relies on precisely coordinated, activity-dependent neurotransmitter release.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref> A fundamental step in this pathway is the fusion of synaptic vesicles with the presynaptic plasma membrane. Soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins mediate membrane fusion and are essential for the fusion of synaptic vesicles.<xref rid="bib1" ref-type="bibr">1</xref>, <xref rid="bib2" ref-type="bibr">2</xref> At mammalian central nervous system (CNS) synapses, neuronal SNAREs consist of vesicle-associated membrane protein 2 (VAMP2, also called synaptobrevin-2) on the vesicle membrane (v-SNARE) and the binary complex of syntaxin1A (STX1A) and synaptosomal-associated protein 25 Kd (SNAP25) on the plasma membrane (target or t-SNARE).<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> The v- and t-SNARE proteins assemble in a polarized manner starting from the N termini distal from the&#xA0;membranes and proceeding towards the C termini and are held together by discrete interacting residues (numbered -7 to +8), including 15 hydrophobic contacts and central ionic residues.<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref> This &#x201C;zippering&#x201D; process pulls the membranes together and provides the energy to fuse the lipid bilayers.<xref rid="bib5" ref-type="bibr">5</xref>, <xref rid="bib6" ref-type="bibr">6</xref> The SNAREs alone are sufficient to drive fusion of synaptic vesicles, but this process is tightly regulated by a number of synaptic proteins to enable Ca<sup>2+</sup>-regulated neurotransmitter release.<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> The key regulatory elements at excitatory CNS synapses include chaperones (Munc18 and Munc13), the primary Ca<sup>2+</sup> sensor synaptotagmin-1, and the auxiliary protein complexin.<xref rid="bib7" ref-type="bibr">7</xref>, <xref rid="bib8" ref-type="bibr">8</xref>, <xref rid="bib9" ref-type="bibr">9</xref>, <xref rid="bib10" ref-type="bibr">10</xref></p>
      <p id="p0015"><italic>VAMP2</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="185881" id="intref0010">185881</ext-link>) encodes a neuronal v-SNARE essential for the fusion of synaptic vesicles at mammalian central nerve terminals.<xref rid="bib5" ref-type="bibr">5</xref>, <xref rid="bib6" ref-type="bibr">6</xref>, <xref rid="bib7" ref-type="bibr">7</xref> Introduction of specific engineered mutations affecting its SNARE motif has been reported to alter vesicle fusion <italic>in&#xA0;vitro</italic> by impairing either formation of the SNARE complex or the interaction of VAMP2 with other (auxiliary) presynaptic proteins.<xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib12" ref-type="bibr">12</xref>
<italic>Vamp2</italic><sup>&#x2212;/&#x2212;</sup> mice present severely decreased rates of both spontaneous and Ca<sup>2+</sup>-triggered synaptic-vesicle fusion, and these mice&#xA0;die immediately after birth.<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref> Also, synapses from VAMP2-deficient mice display changes in synaptic-vesicle morphology and size&#x2014;and delayed stimulus-dependent endocytosis.<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> Thus, VAMP2 exerts a complex influence on synaptic transmission; it plays fundamental roles in vesicle fusion, neurotransmitter release, and vesicle endocytosis. Despite the critical role of VAMP2 in presynaptic molecular events, little is known of the consequences of disrupted <italic>VAMP2</italic> function in human neurodevelopment.</p>
      <p id="p0020">Here, we describe five unrelated individuals who had shown hypotonia since birth and who had intellectual disability (ID) with autistic features, including variable motor stereotypies resembling Rett syndrome (RTT), and, in&#xA0;some children, also central visual impairment, hyperkinetic movements, and epilepsy and/or electroencephalography (EEG) abnormalities. <xref rid="tbl1" ref-type="table">Table 1</xref> summarizes the detailed phenotypes of the individuals (1&#x2013;5), aged between 3 and 14 years.<table-wrap position="float" id="tbl1"><label>Table 1</label><caption><p>Clinical Features of Individuals with <italic>De Novo VAMP2</italic> Mutations</p></caption><table frame="hsides" rules="groups"><thead><tr><th><bold>Individual Number Gender Age</bold></th><th><bold>Variant</bold></th><th><bold>Growth/OFC</bold></th><th><bold>Hypotonia/DD</bold></th><th><bold>ID</bold></th><th><bold>Epileptic Seizures</bold></th><th><bold>EEG</bold></th><th><bold>ASD</bold></th><th><bold>RTT-Like Features</bold></th><th><bold>Movement Disorder</bold></th><th><bold>Central Visual Defects</bold></th><th><bold>Speech Impairment</bold></th><th><bold>Brain Imaging</bold></th><th><bold>Additional Features</bold></th></tr></thead><tbody><tr><td>1<break/>F<break/>3 yr</td><td>c.223T&gt;C, p.Ser75Pro</td><td>normal</td><td>yes</td><td>severe</td><td>no</td><td>high-voltage delta activity, sharp wave-slow wave complexes</td><td>yes</td><td>stereotyped hand movements, absent purposeful hand movements</td><td>choreic movement,<break/>flapping, dystonic postures</td><td>yes</td><td>absent speech</td><td>thin corpus callosum, delayed myelination</td><td>inability to walk</td></tr><tr><td>2<break/>M<break/>10 yr</td><td>c.233A&gt;C, p.Glu78Ala</td><td>normal</td><td>yes</td><td>severe</td><td>focal seizures, GTCS</td><td>fast rhythmic activity, sharp wave-slow wave complexes</td><td>yes</td><td>body rocking, head banging, screaming, absent purposeful hand movements</td><td>generalized<break/>chorea</td><td>yes</td><td>absent speech</td><td>unremarkable</td><td>abnormal behavior,<break/>self-injury,<break/>inability to walk</td></tr><tr><td>3<break/>M<break/>13yr</td><td>c.230T&gt;C, p.Phe77Ser</td><td>normal</td><td>yes</td><td>severe</td><td>infantile spasms,<break/>convulsive status epilepticus</td><td>disorganized EEG paroxysms</td><td>yes</td><td>stereotyped hand movements, absent purposeful hand movements</td><td>choreic movement, myoclonic jerks</td><td>yes</td><td>absent speech</td><td>unremarkable</td><td>abnormal behavior, inability to walk,<break/>severe constipation</td></tr><tr><td>4<break/>M<break/>14yr</td><td>c.128_130delTGG, p.Val43del</td><td>normal</td><td>yes</td><td>moderate</td><td>focal seizures</td><td>generalized and multifocal abnormalities</td><td>yes</td><td>stereotyped hand movements (wringing), absent purposeful hand movements</td><td>no</td><td>no</td><td>only 5&#x2013;10 spoken words</td><td>unremarkable</td><td>clumsiness, abnormal behavior</td></tr><tr><td>5<break/>F<break/>3 yr</td><td>c.135_137delCAT, p.Ile45del</td><td>normal</td><td>yes</td><td>moderate</td><td>no</td><td>disorganized EEG paroxysms</td><td>yes</td><td>stereotyped hand movements (washing)</td><td>no</td><td>no</td><td>only 5 spoken words</td><td>unremarkable</td><td>abnormal behavior</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations are as follows: ASD = autism spectrum disorder; DD = developmental delay; EEG = electroencephalography; FC = focal seizures; GTCS = generalized tonic-clonic seizures; ID = intellectual disability; and OFC = occipital-frontal circumference. Variants are named according to the GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_014232" id="intref0165">NM_014232</ext-link> reference transcript.</p></fn></table-wrap-foot></table-wrap></p>
      <p id="p0025">In all affected children, family histories, pregnancies, and birth histories were unremarkable, and neurodevelopmental impairment occurred within the first year of life. The earliest sign of neurological involvement was axial hypotonia at birth. Poor visual fixation (with only brief and occasional visual contact, lasting up to a few seconds) had been evident since the first months of life in three affected individuals (1&#x2013;3); these individuals were later diagnosed with central visual impairment (<xref rid="tbl1" ref-type="table">Table 1</xref>). Three children (individuals 1&#x2013;3) exhibited a hyperkinetic movement disorder starting in the first year of life (<xref rid="mmc2" ref-type="supplementary-material">Videos S1</xref>, <xref rid="mmc3" ref-type="supplementary-material">S2</xref>, <xref rid="mmc4" ref-type="supplementary-material">S3</xref>, and <xref rid="mmc5" ref-type="supplementary-material">S4</xref>). Abnormal movements ranged from dystonic posturing (mainly involving the trunk, neck, and lower limbs) and moderate chorea (individuals 1 and 3) to a mixed-movement disorder with severe chorea and dystonic posturing (individual 2) or myoclonic jerks (individual 3). All children showed autistic features, typically including flapping or flailing of the arms, as well as hand wringing or clapping. Additional repetitive behavior patterns included body rocking and head banging. Self-injurious behaviors were evident in individual 2. A virtual absence of purposeful hand movements was present in all cases (<xref rid="tbl1" ref-type="table">Table 1</xref>, <xref rid="mmc2" ref-type="supplementary-material">Videos S1</xref>, <xref rid="mmc1" ref-type="supplementary-material">S2</xref>, <xref rid="mmc1" ref-type="supplementary-material">S3</xref>, <xref rid="mmc1" ref-type="supplementary-material">S4</xref>, and <xref rid="mmc1" ref-type="supplementary-material">S5</xref>). Motor development in individuals 1&#x2013;3 was severely impaired, and these children had not attained the ability to walk. Severe language impairment was present in the three more severely affected children (individuals 1&#x2013;3), none of whom had attained meaningful speech production, but individuals 4 and 5 were capable of saying 5&#x2013;10 words (<xref rid="tbl1" ref-type="table">Table 1</xref>).</p>
      <p id="p0030">
        <supplementary-material content-type="local-data" id="mmc2">
          <caption>
            <title>Video S1. Individual 1 at the Ages of 2, 5, and 6 Months</title>
            <p>Individual 1, with the <italic>de novo</italic> p.Ser75Pro variant, presented with hypotonia at the age of 2&#xA0;months; at the age of 5&#xA0;months, she showed staring, a hyperkinetic movement disorder, flapping, hand stereotypies, and automatisms (hand to mouth); at the age of 6&#xA0;months, when the individual is in the pushchair, note the virtual absence of purposeful hand movements.</p>
          </caption>
          <media xlink:href="mmc2.mp4"/>
        </supplementary-material>
      </p>
      <p id="p0035">
        <supplementary-material content-type="local-data" id="mmc3">
          <caption>
            <title>Video S2. Individual 1 at the Age of 15 Months</title>
            <p>Individual 1, with the <italic>de novo</italic> p.Ser75Pro variant, presented with hypotonia, developmental delay, an inability to attain sitting position, poor visual contact, flapping, hand stereotypies (washing), choreic-predominant movement disorder, dystonic postures, staring, and automatisms (hand to mouth).</p>
          </caption>
          <media xlink:href="mmc3.mp4"/>
        </supplementary-material>
      </p>
      <p id="p0040">
        <supplementary-material content-type="local-data" id="mmc4">
          <caption>
            <title>Video S3. Individual 2 at the Age of 6 Years</title>
            <p>Individual 2, with the <italic>de novo</italic> p.Glu78Ala variant, at the age of 6 years presented with hypotonia, developmental delay, lack of purposeful hand movements, automatisms (hand to mouth), backward falling, and dystonic posturing of the four limbs, followed by severe generalized choreic movements.</p>
          </caption>
          <media xlink:href="mmc4.mp4"/>
        </supplementary-material>
      </p>
      <p id="p0045">
        <supplementary-material content-type="local-data" id="mmc5">
          <caption>
            <title>Video S4. Individual 3 at the Age of 12 Years</title>
            <p>Individual 3, with the <italic>de novo</italic> p.Phe77Ser, presented with hypotonia, developmental delay, poor visual contact, a virtual absence of purposeful hand movements, stereotypies (hand clapping), and generalized choreic movements with myoclonic jerks.</p>
          </caption>
          <media xlink:href="mmc5.mp4"/>
        </supplementary-material>
      </p>
      <p id="p0050">
        <supplementary-material content-type="local-data" id="mmc6">
          <caption>
            <title>Video S5. Individual 4 at the Age of 14 Years</title>
            <p>Individual 4, with the <italic>de novo</italic> p.Val43del variant, at the age of 14 years presented some motor clumsiness and hand stereotypies (washing, clapping).</p>
          </caption>
          <media xlink:href="mmc6.mp4"/>
        </supplementary-material>
      </p>
      <p id="p0055">Seizures or abnormal EEG occurred in four affected individuals. Individual 1 did not present with epileptic seizures, but ictal EEG recording at the age of 15&#xA0;months showed high-voltage delta activity with interspersed sharp-and-slow-wave complexes over the right central and posterior brain regions. Individual 2 suffered from multiple focal seizures per day; these started shortly after birth and were characterized on EEG by fast rhythmic activity followed by sharp-and-slow-wave complexes (<xref rid="mmc1" ref-type="supplementary-material">Figure&#xA0;S1</xref>). At 12&#xA0;months, individual 3 presented with infantile spasms that were associated with diffuse EEG paroxysms. Individual 4 developed infrequent staring episodes with eyelid myoclonia at 5 years of age and had a single episode of non-convulsive <italic>status epilepticus</italic> at the age of 11 years. Several anti-epileptic drugs, including valproic acid, vigabatrin, and lamotrigine, have been trialed in individuals 2&#x2013;4 (<xref rid="mmc1" ref-type="supplementary-material">see Supplemental Data</xref>); beneficial effects of valproic acid treatment were noted in individual 4, who has been seizure-free since the age of 12 years and has had normal follow-up EEGs. Individual 2 underwent a craniotomy for grid placement at the age of 6&#xA0;months and had a right posterior circulation stroke affecting the thalamic and cortical areas; at the age of 18&#xA0;months, he had a right temporal lobectomy. Brain magnetic resonance imaging (MRI) was unrevealing in all children except in individual 1, for whom mild myelination delay and a posteriorly slender corpus callosum was observed at the age of 2 years (<xref rid="fig1" ref-type="fig">Figure&#xA0;1</xref>).<fig id="fig1"><label>Figure&#xA0;1</label><caption><p>Brain MRI Scan of Individual 1, Who Harbors a <italic>De Novo</italic> VAMP2 p.Ser75Pro Variant, at the Age of 2 Years</p><p>The panel shows axial T2-weighted, sagittal T1-weighted, and coronal T1-weighted MR images. There is some generalized delay in the maturation of myelin and a reduced volume of the cerebral white matter posteriorly. (Yellow arrows show a posteriorly slender corpus callosum.) The optic nerves and chiasm are hypoplastic (red arrows).</p></caption><graphic xlink:href="gr1"/></fig></p>
      <p id="p0060">The clinical features summarized above are consistent with a diagnosis of neurodevelopmental impairment with variable neurological features in all five affected individuals. Extensive initial genetic and biochemical diagnostic investigations for a range of genetic conditions, including non-syndromic ID, epileptic encephalopathies (EEs), EEs with dyskinesia, metabolic disorders, and mitochondrial diseases, were unrevealing (see <xref rid="mmc1" ref-type="supplementary-material">Supplemental Data</xref>). Affected children were recruited for genetic analysis through the use of whole-exome sequencing (WES) at five centers. Written informed consent was obtained for all individuals and their relatives, after which DNA was extracted from peripheral lymphocytes according to standard protocols. The study was approved by the local ethics committee at University College London Hospitals (project 06/N076) and at the participating institutions. Variants of interest in <italic>VAMP2</italic> were identified by WES of trios and confirmed by Sanger sequencing in all cases. Libraries were prepared from parents&#x2019; and affected individuals&#x2019; DNA, and exomes were captured and sequenced on Illumina sequencers. Raw data were processed and filtered with established pipelines and then annotated, and the Exome variant server ESP6500 was used for assessments of variant frequency in the control population (see <xref rid="mmc1" ref-type="supplementary-material">Supplemental Data</xref>). Only exonic and donor and acceptor splicing variants were considered. Priority was given to rare variants (that had a genomic evolutionary rate profiling [GERP] score &gt;2 and were present at &lt;1% in public databases, including those of the 1000 Genomes Project, NHLBI Exome Variant Server, Complete Genomics 69, and Exome Aggregation Consortium [ExAC v0.2]). Synonymous variants were not considered. Following their respective analysis pipelines,<xref rid="bib15" ref-type="bibr">15</xref>, <xref rid="bib16" ref-type="bibr">16</xref>, <xref rid="bib17" ref-type="bibr">17</xref>, <xref rid="bib18" ref-type="bibr">18</xref> participating centers generated a list of candidate variants filtered against variants from public databases according to modes of inheritance, then compared their results through international research networks and variant databases.<xref rid="bib19" ref-type="bibr">19</xref>, <xref rid="bib20" ref-type="bibr">20</xref></p>
      <p id="p0065">Three <italic>de novo</italic> non-synonymous variants in <italic>VAMP2</italic> [NM_014232: c.223T&gt;C (p.Ser75Pro), c.230T&gt;C (p.Phe77Ser), c.233A&gt;C (p.Glu78Ala)] were identified in three affected individuals (1&#x2013;3) recruited and studied at different centers as part of different research initiatives (see <xref rid="mmc1" ref-type="supplementary-material">Supplemental Data</xref>). We then analyzed the genetic data from the SYNaPS Study Group collection of exomes and genomes from over 4,000 individuals affected with early-onset neurological disorders (including &#x223C;250 children with undiagnosed neurodevelopmental impairment and epilepsy) for variants in <italic>VAMP2</italic> and identified a child (individual 4), carrying a&#xA0;<italic>de novo</italic> single amino acid deletion at position 43 [NM_014232: c.128_130delTGG (p.Val43del)] (<xref rid="fig2" ref-type="fig">Figures 2</xref>A and 2B). We next used web-based tools<xref rid="bib19" ref-type="bibr">19</xref>, <xref rid="bib20" ref-type="bibr">20</xref> to screen <italic>VAMP2</italic> variants within exome and genome datasets from established international collaborations; this process identified an additional child (individual 5) carrying a <italic>de novo</italic> single-amino-acid deletion at position 45 [GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_014232" id="intref0015">NM_014232</ext-link>, c.135_137delCAT (p.Ile45del)] (see <xref rid="mmc1" ref-type="supplementary-material">Supplemental Data</xref>).<fig id="fig2"><label>Figure&#xA0;2</label><caption><p><italic>VAMP2</italic> Intragenic <italic>De Novo</italic> Variants Identified in This Study</p><p>(A) Individuals carrying <italic>de novo VAMP2</italic> intragenic variants; note the hand stereotypies.</p><p>(B) Sanger sequences of five kindreds with <italic>de novo VAMP2</italic> intragenic variants. Chromatograms of individuals 1&#x2013;5 and their parents confirm the <italic>de-novo</italic> occurrence of the <italic>VAMP2</italic> variants in all cases. M/+ denotes the indicated <italic>VAMP2</italic> variant in the heterozygous state, and +/+ denotes homozygous wild-type sequence. Mutant bases in the probands are indicated by a red arrow.</p><p>(C) Schematic depiction of the human VAMP2 protein (GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-p:NP_055047.2" id="intref0135">NP_055047.2</ext-link>) indicating the positions of the variants identified in this study.</p><p>(D) Multiple alignment showing complete conservation across species and VAMP1 homolog (GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-p:NP_055046.1" id="intref0140">NP_055046.1</ext-link>) of the residues affected by the variants identified in this study (these variants are highlighted in yellow). Human VAMP2 (GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-p:NP_055047.2" id="intref0145">NP_055047.2</ext-link>), chimpanzee VAMP2 (UniProt: JAA33755.1), marmoset VAMP2 (UniProt: JAB33896.1), rat VAMP2 (NP_036795.1), rabbit VAMP2 (XP_008268978.1), cow VAMP2 (GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-p:NP_776908.1" id="intref0150">NP_776908.1</ext-link>), dog VAMP2 (GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-p:XP_005620068.1" id="intref0155">XP_005620068.1</ext-link>), zebrafish VAMP2 (GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-p:NP_956299.1" id="intref0160">NP_956299.1</ext-link>).</p></caption><graphic xlink:href="gr2"/></fig></p>
      <p id="p0070">All the identified variants were absent from the Genome Aggregation Database and ExAC, and all displayed high conservation (mean: GERP<sup>++</sup> 5.26) and <italic>in silico</italic> pathogenic predictor (mean: CADD_Phred 26.9) scores (see <xref rid="mmc1" ref-type="supplementary-material">Supplemental Data</xref>). In the ExAC database (last accessed January 30, 2018), which contains exomes from 60,706 unrelated individuals, there are no listed loss-of-function variants in <italic>VAMP2,</italic> and only two non-synonymous variants (p.Asn49Lys [p.Val50Met]) are present within the SNARE motif (amino acids 31&#x2013;91).</p>
      <p id="p0075">The <italic>de novo</italic> non-synonymous variants identified in this study cluster in close proximity within the C-terminal portion of the SNARE motif (<xref rid="fig2" ref-type="fig">Figure&#xA0;2</xref>C). Interspecies alignment of protein sequences generated with Clustal Omega show that all mutations occur within the SNARE motif at residues highly conserved through evolution (<xref rid="fig2" ref-type="fig">Figure&#xA0;2</xref>D). <xref rid="fig3" ref-type="fig">Figure&#xA0;3</xref> shows positions of the mutated amino acids within a 3D structure of the VAMP2 ectodomain in complex with STX1A and SNAP25. Replacement analysis shows that the p.Ser75Pro variant will result in the loss of two hydrogen bonds, one interchain between Ser75 of VAMP2 and Tyr243 of STX1A and one intrachain between Ser75 and Gln71, although the p.Phe77Ser variant introduces a hydrophilic residue in an otherwise hydrophobic region and the p.Glu78Ala variant disrupts the hydrogen bond between Glu78 of VAMP2 and Arg246 of STX1A.<fig id="fig3"><label>Figure&#xA0;3</label><caption><p>Molecular Modeling of the Identified <italic>De Novo</italic> VAMP2 Non-Synonymous Variants</p><p>Comparison between the p.Ser75Pro (A), p.Phe77Ser (B), and p.Glu78Ala (C) mutant conformation within the SNARE complex (left panel, red square). The wild-type conformation is shown in the middle panel, and the mutated residues are shown in the right panel. Variant p.Ser75Pro causes the loss of two hydrogen bonds, one interchain between Ser75 of VAMP2 and Tyr243 of STX1A and one intrachain&#xA0;between Ser75 and Gln71; variant p.Phe77Ser introduces a hydrophilic residue in an otherwise hydrophobic region; and variant p.Glu78Ala causes the loss of&#xA0;a hydrogen bond between Glu78 of VAMP2 and Arg246 of STX1A. Modeling of the VAMP2 ectodomain (green for WT, light green for mutants) in complex with STX1A (orange for WT, light orange for mutants) and Snap25 (blue and cyan for WT, marine and aquamarine for mutants); configurations are as seen 100&#xA0;ns into the molecular dynamic simulation. The complexes were modeled from the humanized 3HD7 complex. Water molecules and ions are not shown.</p></caption><graphic xlink:href="gr3"/></fig></p>
      <p id="p0080">To determine whether these disease-associated variants affect VAMP2 structure and SNARE complex stability, we performed 100&#xA0;ns molecular dynamics (MD) simulations by using a humanized version of the neuronal SNARE complex (PDB <ext-link ext-link-type="uri" xlink:href="pdb:3HD7" id="intref0020">3HD7</ext-link>, see <xref rid="mmc1" ref-type="supplementary-material">Supplemental Data</xref>). During the simulations, the WT and p.Ser75Pro seemed to reach a stationary state, but major rearrangements were still observed for p.Phe77Ser and p.Glu78Ala at the end of the simulation. This was evident in their backbone root-mean-square deviation (RMSD) and radius of gyration, which measure the divergence of the mutant protein structure from its initial structure over the course of the simulation. In all cases, the most mobile portion of the chain was that close to the C terminus, as seen in their root mean squared fluctuation (RMSF). The RMSF further indicates that in all cases, the variants increase the mobility of the backbone, and this effect is particularly evident for p.Glu78Ala. Overall rearrangements of the complex are shown in <xref rid="mmc1" ref-type="supplementary-material">Figures S2&#x2013;S3</xref>.</p>
      <p id="p0085">To examine <italic>VAMP2</italic> expression across CNS regions, we used microarray data (Affymetrix Exon 1.0 ST) from human post-mortem brain tissues as previously described.<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref> This analysis showed the highest <italic>VAMP2</italic> expression in the putamen and the frontal lobes (<xref rid="mmc1" ref-type="supplementary-material">Figure&#xA0;S4</xref>).</p>
      <p id="p0090">To evaluate the functional consequence of <italic>VAMP2</italic> variants, we employed the reconstituted, lipid-mixing assay based on NBD (N-[7-nitro-2-1, 3-benzoxadiazol-4-yl])-to-RHO (lissamine rhodamine B) energy transfer (see <xref rid="mmc1" ref-type="supplementary-material">Supplemental Data</xref>). In this assay, the VAMP2 (wild-type [WT] or mutant) was included in the fluorescent donor liposomes, whereas the t-SNAREs were reconstituted into the non-fluorescent acceptor liposomes. We read out membrane fusion between the donor and acceptor liposome mixing by quantifying increased fluorescence resulting from the dequenching of NBD fluorescence (<xref rid="fig4" ref-type="fig">Figure&#xA0;4</xref>A). To this end, we purified WT VAMP2 and the variant protein along with the t-SNARE complex by using a bacterial expression system as previously described.<xref rid="bib22" ref-type="bibr">22</xref>, <xref rid="bib23" ref-type="bibr">23</xref> We were able to purify the p.Ser75Pro and p.Glu78Ala variants, and Coomassie-stained SDS-PAGE analysis showed that these variants were structurally intact and highly pure with no contamination (<xref rid="mmc1" ref-type="supplementary-material">Figure&#xA0;S5</xref>). However, all attempts to isolate the p.Phe77Ser were unsuccessful. We therefore limited our <italic>in&#xA0;vitro</italic> fusion analysis to the two remaining non-synonymous variants (p.Ser75Pro and p.Glu78Ala).<fig id="fig4"><label>Figure&#xA0;4</label><caption><p>Disease-Associated <italic>VAMP2</italic> Variants Result in Reduced Fusion Rates</p><p>(A) Scheme showing the liposome fusion assay.</p><p>(B) The SDS-PAGE and Coomassie-stained gel image of VAMP2 WT, VAMP2 disease-associated variants (p.Ser75Pro [p.Glu78Ala]), and t-SNARE (syntaxin 1 and SNAP25) reconstitution into donor v- and acceptor t-liposomes, respectively.</p><p>(C) Line graphs showing the average basal (without Munc18-1) increase that occurs in NBD fluorescence as a result of fusion between the v-liposome and t-SNARE liposomes carrying WT or VAMP2 disease variants (p.Ser75Pro [p.Glu78Ala]). Liposome fusion reaction in the presence of CDV was used as negative control.</p><p>(D) Basal fusion quantification, normalized to WT, at the endpoint (60&#xA0;min) as described in (C).</p><p>(E) Line graphs of liposome fusion reaction as in (C), in the presence of 5&#xA0;&#x3BC;M Munc18-1.</p><p>(F) Endpoint fusion quantification, normalized to WT, (60&#xA0;min) of experiment as described in (E). Bar graphs also showed endpoint quantification of a similar experiment that used a v-liposome that contained a mixture of WT and mutant VAMP2 proteins. Data were from at least four independent replicates and presented as means plus SD. <sup>&#x2217;</sup>p &lt; 0.05; <sup>&#x2217;&#x2217;</sup> p &lt; 0.01; <sup>&#x2217;&#x2217;&#x2217;</sup> p &lt; 0.001; n.s., not significant (p &gt; 0.05).</p></caption><graphic xlink:href="gr4"/></fig></p>
      <p id="p0095">As shown in <xref rid="fig4" ref-type="fig">Figures 4</xref>C&#x2013;4F, the VAMP2 disease-associated variant p.Ser75Pro reduced the rate and extent of fusion compared to that seen with VAMP2 WT, whereas the p.Glu78Ala variant had little to no effect (<xref rid="fig4" ref-type="fig">Figures 4</xref>C and 4D). The reduction in the fusion associated with p.Ser75Pro was estimated to be approximately 25% that in the WT, suggesting that the introduction of a proline residue at this site most likely interferes with the proper assembly of the SNARE proteins and thus affects VAMP2 fusion properties, whereas the fusion profile associated with the p.Glu78Ala was indistinguishable from that of the WT.</p>
      <p id="p0100">Earlier studies have shown that Munc18 chaperones SNARE assembly via interactions with the VAMP2 C-terminal region.<xref rid="bib12" ref-type="bibr">12</xref>, <xref rid="bib24" ref-type="bibr">24</xref> We therefore investigated the effect of the disease variants under Munc18-activated conditions. As expected, inclusion of Munc18-1 produced an approximately 2-fold increase in the rate and extent of fusion when WT VAMP2 was used (<xref rid="fig4" ref-type="fig">Figure&#xA0;4</xref>E). Strikingly, Munc18 could not activate the fusion mediated by the VAMP2 p.Ser75Pro variant (<xref rid="fig4" ref-type="fig">Figure&#xA0;4</xref>E). Consequently, we observed a significant (&gt;90%) loss-of-function phenotype with the p.Ser75Pro variant under these conditions. In contrast, Munc18 was able to activate the fusion mediated by VAMP2 p.Glu78Ala, confirming that this variant does not affect the SNARE assembly process or its activation. To accurately emulate the physiological make-up of the individuals carrying heterozygous <italic>de novo VAMP2</italic> variants, we also tested the effect of replacing half the copies of WT VAMP2 with the disease variants (<xref rid="mmc1" ref-type="supplementary-material">Figure&#xA0;S4</xref>). Remarkably, in the case of p.Ser75Pro, the fusion profile for the mixed v-liposomes (50:50 WT:mutant) was identical to the fusion profile for the homogenous samples containing only the mutant proteins (<xref rid="fig4" ref-type="fig">Figure&#xA0;4</xref>F; <xref rid="mmc1" ref-type="supplementary-material">Figure&#xA0;S4</xref>). This implies that p.Ser75Pro mutant dominantly interferes with WT (<xref rid="fig4" ref-type="fig">Figure&#xA0;4</xref>F), and this could readily explain the pathological phenotype observed with this variant.</p>
      <p id="p0105">Our genetic and functional studies show that <italic>de novo</italic> mutations in <italic>VAMP2</italic> cause neurodevelopmental impairment associated with variable clinical features. Individuals 1&#x2013;3, carrying <italic>de novo</italic> non-synonymous variants affecting the C terminus of the VAMP2 SNARE motif (residues 75, 77, and 78), presented a severe neurological phenotype with motor impairment (and inability to walk), central visual deficits, hyperkinetic movements, and, in two of them, epilepsy starting in infancy. Individuals 4 and 5, carrying <italic>de novo</italic> single-amino-acid deletions involving residues at positions 43 and 45, presented a less severe neurological involvement, acquired the ability to walk, and were able to pronounce a few words. MD simulations showed that missense mutations in the C terminus induce higher flexibility of this region within the assembled SNARE complexes. The <italic>in&#xA0;vitro</italic> lipid-mixing assay revealed a significant defect in vesicle fusion as a consequence of the p.Ser75Pro variant, but p.Glu78Ala had no clear functional consequence. The pathophysiological phenotype for the p.Glu78Ala variant might be due to impaired interactions with regulatory proteins that were not included in the <italic>in&#xA0;vitro</italic> assay. Notably, the assembly of the C-terminal region of the SNARE proteins is considered critical to driving membrane fusion,<xref rid="bib5" ref-type="bibr">5</xref>, <xref rid="bib25" ref-type="bibr">25</xref> and several synaptic regulatory proteins modulate vesicle fusion by binding the C-terminal portion of the SNARE complex.<xref rid="bib12" ref-type="bibr">12</xref>, <xref rid="bib23" ref-type="bibr">23</xref>, <xref rid="bib24" ref-type="bibr">24</xref> Thus, mutations affecting this region could disturb the SNARE complex assembly by less-efficient partnering of cognate SNARE proteins and/or disrupt its association with regulatory elements such as Munc18-1 or Synaptotagmin. In the physiological context, this would manifest as the perturbation of Ca<sup>2+</sup>-triggered neurotransmitter release. Even a slight alteration of the fusion kinetics <italic>in&#xA0;vitro</italic> would translate to a dramatic effect on the release of neurotransmitters release at the neuronal synapses. This might explain the severe neurodevelopmental impairment observed in the VAMP2 synaptopathy. Interestingly, variants affecting the Ser75 residue have previously been shown to impair the Munc18-1 stimulatory activity by impairing its ability to regulate trans-SNARE zippering,<xref rid="bib12" ref-type="bibr">12</xref>, <xref rid="bib23" ref-type="bibr">23</xref> and variants involving residue Glu78 can also affect Ca<sup>2+</sup>-regulated neurotransmitter release.<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref></p>
      <p id="p0110">The present work adds to the evidence that neurodevelopmental disorders (NDDs) have a strong genetic component and encompass a range of frequently co-existing conditions, including ID, developmental delay (DD), and autism spectrum disorders (ASDs).<xref rid="bib27" ref-type="bibr">27</xref>, <xref rid="bib28" ref-type="bibr">28</xref> Neurodevelopmental impairment, epilepsy, and movement disorders also frequently co-exist.<xref rid="bib29" ref-type="bibr">29</xref>, <xref rid="bib30" ref-type="bibr">30</xref> Rare variants in genes that encode a number of presynaptic proteins involved in Ca<sup>2+</sup>-regulated neurotransmitter release have been identified in individuals affected by a spectrum of neurological disorders. These include the following:<list list-type="simple" id="ulist0010"><list-item id="u0010"><p id="p0115">1. variants in <italic>SNAP25</italic> (MIM: 60322) isoforms <italic>SNAP25a</italic> and <italic>SNAP25b;</italic> these variants have been identified in association with ID, seizures, and myasthenia<xref rid="bib31" ref-type="bibr">31</xref>, <xref rid="bib32" ref-type="bibr">32</xref></p></list-item><list-item id="u0015"><p id="p0120">2. variants in <italic>SYT1</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="185605" id="intref0025">185605</ext-link>), which encodes the&#xA0;Ca<sup>2+</sup>-sensor synaptotagmin-1 required for evoked synchronous fusion; these variants are found in individuals with NDDs and hyperkinetic movements<xref rid="bib33" ref-type="bibr">33</xref>, <xref rid="bib34" ref-type="bibr">34</xref></p></list-item><list-item id="u0020"><p id="p0125">3. variants in genes encoding the RIM interactor PNKD or the SNAP25 and synaptotagmin-1 interactor PRRT2; these variants have been identified in different forms of dyskinesias and seizures (MIM: <ext-link ext-link-type="omim" xlink:href="128200" id="intref0030">128200</ext-link>; MIM: 60575)<xref rid="bib35" ref-type="bibr">35</xref>, <xref rid="bib36" ref-type="bibr">36</xref></p></list-item><list-item id="u0025"><p id="p0130">4. variants in <italic>UNC13A</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="609894" id="intref0035">609894</ext-link>), encoding the synaptic regulator Munc13-1; these variants have been linked to an NDD with involuntary movements<xref rid="bib37" ref-type="bibr"><sup>37</sup></xref></p></list-item><list-item id="u0030"><p id="p0135">5. variants in <italic>STXBP1</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="602926" id="intref0040">602926</ext-link>), encoding Munc18-1; these variants cause NDDs with epilepsy and autistic features<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref></p></list-item></list></p>
      <p id="p0140">The phenotypes associated with the VAMP2 synaptopathy reported here are reminiscent of the variability reported in some individuals who have <italic>de-novo</italic> variants in <italic>STXBP1</italic> or in <italic>SYT1</italic> and who can present with a combination of neurodevelopmental impairment, stereotypies, hyperkinetic movements (including chorea and dystonia), and EEG anomalies or epileptic syndromes of variable severity.<xref rid="bib33" ref-type="bibr">33</xref>, <xref rid="bib39" ref-type="bibr">39</xref></p>
      <p id="p0145">Notably, a heterozygous mutation in a synaptobrevin homolog, <italic>VAMP1</italic>, which encodes a protein involved in vesicle fusion mainly at neuromuscular synapses,<xref rid="bib40" ref-type="bibr"><sup>40</sup></xref> has been linked to spastic ataxia in families from Newfoundland.<xref rid="bib41" ref-type="bibr"><sup>41</sup></xref> More recently, biallelic mutations in <italic>VAMP1</italic> have been identified in association with a phenotype of congenital hypotonia and muscle weakness, and in three of these families neurophysiological evidence of presynaptic neuromuscular transmission impairment was detected and led to a diagnosis of presynaptic congenital myasthenic syndrome.<xref rid="bib42" ref-type="bibr">42</xref>, <xref rid="bib43" ref-type="bibr">43</xref>, <xref rid="bib44" ref-type="bibr">44</xref></p>
      <p id="p0150">In conclusion, we have identified a neurodevelopmental disease that is variably associated with additional neurological features, including epilepsy and hyperkinetic movements, and that is caused by <italic>de novo</italic> mutations in <italic>VAMP2</italic>. These results further delineate an emerging spectrum of human core synaptopathies caused by variants in genes that encode SNAREs and essential regulatory components of the synaptic machinery. The hallmark of these disorders is impaired presynaptic neurotransmission at nerve terminals; this impaired neurotransmission results in a wide array of (often overlapping) clinical features, including neurodevelopmental impairment, weakness, seizures, and abnormal movements. The genetic synaptopathy caused by <italic>VAMP2</italic> mutations highlights the key roles of this gene in human brain development and function. Variability in the effects of different <italic>VAMP2</italic> mutants under <italic>in&#xA0;vitro</italic> conditions points toward mutation-specific mechanisms underlying the presynaptic defect of the affected children, and this variability highlights a promising area of future research.</p>
    </sec>
    <sec id="sec2">
      <title>Declaration of Interests</title>
      <p id="p0155">The authors declare no competing interests.</p>
    </sec>
  </body>
  <back>
    <ref-list id="cebib0010">
      <title>References</title>
      <ref id="bib1">
        <label>1</label>
        <element-citation publication-type="journal" id="sref1">
          <person-group person-group-type="author">
            <name>
              <surname>Jahn</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Fasshauer</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Molecular machines governing exocytosis of synaptic vesicles</article-title>
          <source>Nature</source>
          <volume>490</volume>
          <year>2012</year>
          <fpage>201</fpage>
          <lpage>207</lpage>
          <pub-id pub-id-type="pmid">23060190</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <label>2</label>
        <element-citation publication-type="journal" id="sref2">
          <person-group person-group-type="author">
            <name>
              <surname>Hu</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ahmed</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Melia</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>S&#xF6;llner</surname>
              <given-names>T.H.</given-names>
            </name>
            <name>
              <surname>Mayer</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Rothman</surname>
              <given-names>J.E.</given-names>
            </name>
          </person-group>
          <article-title>Fusion of cells by flipped SNAREs</article-title>
          <source>Science</source>
          <volume>300</volume>
          <year>2003</year>
          <fpage>1745</fpage>
          <lpage>1749</lpage>
          <pub-id pub-id-type="pmid">12805548</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <label>3</label>
        <element-citation publication-type="journal" id="sref3">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>Y.A.</given-names>
            </name>
            <name>
              <surname>Scales</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Doung</surname>
              <given-names>Y.C.</given-names>
            </name>
            <name>
              <surname>Scheller</surname>
              <given-names>R.H.</given-names>
            </name>
          </person-group>
          <article-title>SNARE complex formation is triggered by Ca<sup>2+</sup> and drives membrane fusion</article-title>
          <source>Cell</source>
          <volume>97</volume>
          <year>1999</year>
          <fpage>165</fpage>
          <lpage>174</lpage>
          <pub-id pub-id-type="pmid">10219238</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <label>4</label>
        <element-citation publication-type="journal" id="sref4">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>K&#xFC;mmel</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Coleman</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Reinisch</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Rothman</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Pincet</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>A half-zippered SNARE complex represents a functional intermediate in membrane fusion</article-title>
          <source>J.&#xA0;Am. Chem. Soc.</source>
          <volume>136</volume>
          <year>2014</year>
          <fpage>3456</fpage>
          <lpage>3464</lpage>
          <pub-id pub-id-type="pmid">24533674</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <label>5</label>
        <element-citation publication-type="journal" id="sref5">
          <person-group person-group-type="author">
            <name>
              <surname>Gao</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zorman</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Gundersen</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Xi</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Sirinakis</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Rothman</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Single reconstituted neuronal SNARE complexes zipper in three distinct stages</article-title>
          <source>Science</source>
          <volume>337</volume>
          <year>2012</year>
          <fpage>1340</fpage>
          <lpage>1343</lpage>
          <pub-id pub-id-type="pmid">22903523</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <label>6</label>
        <element-citation publication-type="journal" id="sref6">
          <person-group person-group-type="author">
            <name>
              <surname>Rothman</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>S&#xF6;llner</surname>
              <given-names>T.H.</given-names>
            </name>
          </person-group>
          <article-title>Throttles and dampers: controlling the engine of membrane fusion</article-title>
          <source>Science</source>
          <volume>276</volume>
          <year>1997</year>
          <fpage>1212</fpage>
          <lpage>1213</lpage>
          <pub-id pub-id-type="pmid">9182331</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <label>7</label>
        <element-citation publication-type="journal" id="sref7">
          <person-group person-group-type="author">
            <name>
              <surname>Weber</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Zemelman</surname>
              <given-names>B.V.</given-names>
            </name>
            <name>
              <surname>McNew</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Westermann</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Gmachl</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Parlati</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>S&#xF6;llner</surname>
              <given-names>T.H.</given-names>
            </name>
            <name>
              <surname>Rothman</surname>
              <given-names>J.E.</given-names>
            </name>
          </person-group>
          <article-title>SNAREpins: minimal machinery for membrane fusion</article-title>
          <source>Cell</source>
          <volume>92</volume>
          <year>1998</year>
          <fpage>759</fpage>
          <lpage>772</lpage>
          <pub-id pub-id-type="pmid">9529252</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <label>8</label>
        <element-citation publication-type="journal" id="sref8">
          <person-group person-group-type="author">
            <name>
              <surname>Melia</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>McNew</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Fisher</surname>
              <given-names>L.E.</given-names>
            </name>
            <name>
              <surname>Johnston</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Parlati</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Mahal</surname>
              <given-names>L.K.</given-names>
            </name>
            <name>
              <surname>Sollner</surname>
              <given-names>T.H.</given-names>
            </name>
            <name>
              <surname>Rothman</surname>
              <given-names>J.E.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of membrane fusion by the membrane-proximal coil of the t-SNARE during zippering of SNAREpins</article-title>
          <source>J.&#xA0;Cell Biol.</source>
          <volume>158</volume>
          <year>2002</year>
          <fpage>929</fpage>
          <lpage>940</lpage>
          <pub-id pub-id-type="pmid">12213837</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <label>9</label>
        <element-citation publication-type="journal" id="sref9">
          <person-group person-group-type="author">
            <name>
              <surname>Brunger</surname>
              <given-names>A.T.</given-names>
            </name>
          </person-group>
          <article-title>Structure and function of SNARE and SNARE-interacting proteins</article-title>
          <source>Q.&#xA0;Rev. Biophys.</source>
          <volume>38</volume>
          <year>2005</year>
          <fpage>1</fpage>
          <lpage>47</lpage>
          <pub-id pub-id-type="pmid">16336742</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <label>10</label>
        <element-citation publication-type="journal" id="sref10">
          <person-group person-group-type="author">
            <name>
              <surname>Rizo</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Rosenmund</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Synaptic vesicle fusion</article-title>
          <source>Nat. Struct. Mol. Biol.</source>
          <volume>15</volume>
          <year>2008</year>
          <fpage>665</fpage>
          <lpage>674</lpage>
          <pub-id pub-id-type="pmid">18618940</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <label>11</label>
        <element-citation publication-type="journal" id="sref11">
          <person-group person-group-type="author">
            <name>
              <surname>Hernandez</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Behrmann</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Riedel</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Cypionka</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Farsi</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Walla</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Raunser</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Jahn</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Membrane fusion intermediates via directional and full assembly of the SNARE complex</article-title>
          <source>Science</source>
          <volume>336</volume>
          <year>2012</year>
          <fpage>1581</fpage>
          <lpage>1584</lpage>
          <pub-id pub-id-type="pmid">22653732</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <label>12</label>
        <element-citation publication-type="journal" id="sref12">
          <person-group person-group-type="author">
            <name>
              <surname>Shen</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Rathore</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Gulbranson</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Hua</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Schoppa</surname>
              <given-names>N.E.</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>The trans-SNARE-regulating function of Munc18-1 is essential to synaptic exocytosis</article-title>
          <source>Nat. Commun.</source>
          <volume>6</volume>
          <year>2015</year>
          <fpage>8852</fpage>
          <pub-id pub-id-type="pmid">26572858</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <label>13</label>
        <element-citation publication-type="journal" id="sref13">
          <person-group person-group-type="author">
            <name>
              <surname>Schoch</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>De&#xE1;k</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>K&#xF6;nigstorfer</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Mozhayeva</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sara</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>S&#xFC;dhof</surname>
              <given-names>T.C.</given-names>
            </name>
            <name>
              <surname>Kavalali</surname>
              <given-names>E.T.</given-names>
            </name>
          </person-group>
          <article-title>SNARE function analyzed in synaptobrevin/VAMP knockout mice</article-title>
          <source>Science</source>
          <volume>294</volume>
          <year>2001</year>
          <fpage>1117</fpage>
          <lpage>1122</lpage>
          <pub-id pub-id-type="pmid">11691998</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <label>14</label>
        <element-citation publication-type="journal" id="sref14">
          <person-group person-group-type="author">
            <name>
              <surname>De&#xE1;k</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Schoch</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>S&#xFC;dhof</surname>
              <given-names>T.C.</given-names>
            </name>
            <name>
              <surname>Kavalali</surname>
              <given-names>E.T.</given-names>
            </name>
          </person-group>
          <article-title>Synaptobrevin is essential for fast synaptic-vesicle endocytosis</article-title>
          <source>Nat. Cell Biol.</source>
          <volume>6</volume>
          <year>2004</year>
          <fpage>1102</fpage>
          <lpage>1108</lpage>
          <pub-id pub-id-type="pmid">15475946</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <label>15</label>
        <element-citation publication-type="journal" id="sref15">
          <person-group person-group-type="author">
            <name>
              <surname>Mencacci</surname>
              <given-names>N.E.</given-names>
            </name>
            <name>
              <surname>Kamsteeg</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Nakashima</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>R&#x2019;Bibo</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Balint</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Willemsen</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Wiethoff</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>De Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions</article-title>
          <source>Am. J. Hum. Genet.</source>
          <volume>98</volume>
          <year>2016</year>
          <fpage>763</fpage>
          <lpage>771</lpage>
          <pub-id pub-id-type="pmid">27058447</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <label>16</label>
        <element-citation publication-type="journal" id="sref16">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Gong</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Genetic Evaluation of 114 Chinese Short Stature Children in the Next Generation Era: a Single Center Study</article-title>
          <source>Cell. Physiol. Biochem.</source>
          <volume>49</volume>
          <year>2018</year>
          <fpage>295</fpage>
          <lpage>305</lpage>
          <pub-id pub-id-type="pmid">30138938</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <label>17</label>
        <element-citation publication-type="journal" id="sref17">
          <person-group person-group-type="author">
            <name>
              <surname>Mart&#xED;n-Hern&#xE1;ndez</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez-Garc&#xED;a</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Camacho</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Matilla-Due&#xF1;as</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Garc&#xED;a-Silva</surname>
              <given-names>M.T.</given-names>
            </name>
            <name>
              <surname>Quijada-Fraile</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Corral-Juan</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tejada-Palacios</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>de Las Heras</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Arenas</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>New ATP8A2 gene mutations associated with a novel syndrome: encephalopathy, intellectual disability, severe hypotonia, chorea and optic atrophy</article-title>
          <source>Neurogenetics</source>
          <volume>17</volume>
          <year>2016</year>
          <fpage>259</fpage>
          <lpage>263</lpage>
          <pub-id pub-id-type="pmid">27679995</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <label>18</label>
        <element-citation publication-type="journal" id="sref18">
          <person-group person-group-type="author">
            <name>
              <surname>Salpietro</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Perez-Due&#xF1;as</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Nakashima</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>San Antonio-Arce</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Manole</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Efthymiou</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Vandrovcova</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bettencourt</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Mencacci</surname>
              <given-names>N.E.</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>A homozygous loss-of-function mutation in PDE2A associated to early-onset hereditary chorea</article-title>
          <source>Mov. Disord.</source>
          <volume>33</volume>
          <year>2018</year>
          <fpage>482</fpage>
          <lpage>488</lpage>
          <pub-id pub-id-type="pmid">29392776</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <label>19</label>
        <element-citation publication-type="journal" id="sref19">
          <person-group person-group-type="author">
            <name>
              <surname>Sobreira</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Schiettecatte</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Boehm</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Valle</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Hamosh</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>New tools for Mendelian disease gene identification: PhenoDB variant analysis module; and GeneMatcher, a web-based tool for linking investigators with an interest in the same gene</article-title>
          <source>Hum. Mutat.</source>
          <volume>36</volume>
          <year>2015</year>
          <fpage>425</fpage>
          <lpage>431</lpage>
          <pub-id pub-id-type="pmid">25684268</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <label>20</label>
        <element-citation publication-type="journal" id="sref20">
          <person-group person-group-type="author">
            <name>
              <surname>Sobreira</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Schiettecatte</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Valle</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Hamosh</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>GeneMatcher: A matching tool for connecting investigators with an interest in the same gene</article-title>
          <source>Hum. Mutat.</source>
          <volume>36</volume>
          <year>2015</year>
          <fpage>928</fpage>
          <lpage>930</lpage>
          <pub-id pub-id-type="pmid">26220891</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <label>21</label>
        <element-citation publication-type="journal" id="sref21">
          <person-group person-group-type="author">
            <name>
              <surname>Trabzuni</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ryten</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Imran</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ramasamy</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Weale</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Hardy</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Quality control parameters on a large dataset of regionally dissected human&#xA0;control brains for whole genome expression studies</article-title>
          <source>J.&#xA0;Neurochem.</source>
          <volume>119</volume>
          <year>2011</year>
          <fpage>275</fpage>
          <lpage>282</lpage>
          <pub-id pub-id-type="pmid">21848658</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <label>22</label>
        <element-citation publication-type="journal" id="sref22">
          <person-group person-group-type="author">
            <name>
              <surname>Weber</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Parlati</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>McNew</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Johnston</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Westermann</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>S&#xF6;llner</surname>
              <given-names>T.H.</given-names>
            </name>
            <name>
              <surname>Rothman</surname>
              <given-names>J.E.</given-names>
            </name>
          </person-group>
          <article-title>SNAREpins are functionally resistant to disruption by NSF and alphaSNAP</article-title>
          <source>J.&#xA0;Cell Biol.</source>
          <volume>149</volume>
          <year>2000</year>
          <fpage>1063</fpage>
          <lpage>1072</lpage>
          <pub-id pub-id-type="pmid">10831610</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <label>23</label>
        <element-citation publication-type="journal" id="sref23">
          <person-group person-group-type="author">
            <name>
              <surname>Shen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Tareste</surname>
              <given-names>D.C.</given-names>
            </name>
            <name>
              <surname>Paumet</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Rothman</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Melia</surname>
              <given-names>T.J.</given-names>
            </name>
          </person-group>
          <article-title>Selective activation of cognate SNAREpins by Sec1/Munc18 proteins</article-title>
          <source>Cell</source>
          <volume>128</volume>
          <year>2007</year>
          <fpage>183</fpage>
          <lpage>195</lpage>
          <pub-id pub-id-type="pmid">17218264</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <label>24</label>
        <element-citation publication-type="journal" id="sref24">
          <person-group person-group-type="author">
            <name>
              <surname>S&#xFC;dhof</surname>
              <given-names>T.C.</given-names>
            </name>
            <name>
              <surname>Rothman</surname>
              <given-names>J.E.</given-names>
            </name>
          </person-group>
          <article-title>Membrane fusion: Grappling with SNARE and SM proteins</article-title>
          <source>Science</source>
          <volume>323</volume>
          <year>2009</year>
          <fpage>474</fpage>
          <lpage>477</lpage>
          <pub-id pub-id-type="pmid">19164740</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <label>25</label>
        <element-citation publication-type="journal" id="sref25">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Energetics, kinetics, and pathway of SNARE folding and assembly revealed by optical tweezers</article-title>
          <source>Protein Sci.</source>
          <volume>26</volume>
          <year>2017</year>
          <fpage>1252</fpage>
          <lpage>1265</lpage>
          <pub-id pub-id-type="pmid">28097727</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <label>26</label>
        <element-citation publication-type="journal" id="sref26">
          <person-group person-group-type="author">
            <name>
              <surname>S&#xF8;rensen</surname>
              <given-names>J.B.</given-names>
            </name>
            <name>
              <surname>Matti</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Nehring</surname>
              <given-names>R.B.</given-names>
            </name>
            <name>
              <surname>Voets</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ashery</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Binz</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Neher</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Rettig</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>The SNARE protein SNAP-25 is linked to fast calcium triggering of exocytosis</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>99</volume>
          <year>2002</year>
          <fpage>1627</fpage>
          <lpage>1632</lpage>
          <pub-id pub-id-type="pmid">11830673</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <label>27</label>
        <element-citation publication-type="journal" id="sref27">
          <person-group person-group-type="author">
            <name>
              <surname>Yin</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Chao</surname>
              <given-names>E.S.</given-names>
            </name>
            <name>
              <surname>Soriano</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Cummock</surname>
              <given-names>S.E.</given-names>
            </name>
            <name>
              <surname>Tao</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Pang</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>Otud7a knockout mice recapitulate many neurological features of 15q13.3 microdeletion syndrome</article-title>
          <source>Am. J. Hum. Genet.</source>
          <volume>102</volume>
          <year>2018</year>
          <fpage>296</fpage>
          <lpage>308</lpage>
          <pub-id pub-id-type="pmid">29395075</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <label>28</label>
        <element-citation publication-type="journal" id="sref28">
          <person-group person-group-type="author">
            <name>
              <surname>Reijnders</surname>
              <given-names>M.R.F.</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Alvi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Goos</surname>
              <given-names>J.A.C.</given-names>
            </name>
            <name>
              <surname>Lees</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>de Burca</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Henderson</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kraus</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Mikat</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>de Vries</surname>
              <given-names>B.B.A.</given-names>
            </name>
            <collab>Deciphering Developmental Disorders Study</collab>
          </person-group>
          <article-title>De Novo and inherited loss-of-function variants in TLK2: Clinical and genotype-phenotype evaluation of a distinct neurodevelopmental disorder</article-title>
          <source>Am. J. Hum. Genet.</source>
          <volume>102</volume>
          <year>2018</year>
          <fpage>1195</fpage>
          <lpage>1203</lpage>
          <pub-id pub-id-type="pmid">29861108</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <label>29</label>
        <element-citation publication-type="journal" id="sref29">
          <person-group person-group-type="author">
            <name>
              <surname>McTague</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Howell</surname>
              <given-names>K.B.</given-names>
            </name>
            <name>
              <surname>Cross</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Kurian</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Scheffer</surname>
              <given-names>I.E.</given-names>
            </name>
          </person-group>
          <article-title>The genetic landscape of the epileptic encephalopathies of infancy and childhood</article-title>
          <source>Lancet Neurol.</source>
          <volume>15</volume>
          <year>2016</year>
          <fpage>304</fpage>
          <lpage>316</lpage>
          <pub-id pub-id-type="pmid">26597089</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <label>30</label>
        <element-citation publication-type="journal" id="sref30">
          <person-group person-group-type="author">
            <name>
              <surname>Carecchio</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mencacci</surname>
              <given-names>N.E.</given-names>
            </name>
          </person-group>
          <article-title>Emerging monogenic complex hyperkinetic disorders</article-title>
          <source>Curr. Neurol. Neurosci. Rep.</source>
          <volume>17</volume>
          <year>2017</year>
          <fpage>97</fpage>
          <pub-id pub-id-type="pmid">29086067</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <label>31</label>
        <element-citation publication-type="journal" id="sref31">
          <person-group person-group-type="author">
            <name>
              <surname>Shen</surname>
              <given-names>X.M.</given-names>
            </name>
            <name>
              <surname>Selcen</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Brengman</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Engel</surname>
              <given-names>A.G.</given-names>
            </name>
          </person-group>
          <article-title>Mutant SNAP25B causes myasthenia, cortical hyperexcitability, ataxia, and intellectual disability</article-title>
          <source>Neurology</source>
          <volume>83</volume>
          <year>2014</year>
          <fpage>2247</fpage>
          <lpage>2255</lpage>
          <pub-id pub-id-type="pmid">25381298</pub-id>
        </element-citation>
      </ref>
      <ref id="bib32">
        <label>32</label>
        <element-citation publication-type="journal" id="sref32">
          <person-group person-group-type="author">
            <name>
              <surname>Fukuda</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Imagawa</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Hamanaka</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Fujita</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Mitsuhashi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Miyatake</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mizuguchi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Takata</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Miyake</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Kramer</surname>
              <given-names>U.</given-names>
            </name>
          </person-group>
          <article-title>A novel missense SNAP25b mutation in two affected siblings from an Israeli family showing seizures and cerebellar ataxia</article-title>
          <source>J.&#xA0;Hum. Genet.</source>
          <volume>63</volume>
          <year>2018</year>
          <fpage>673</fpage>
          <lpage>676</lpage>
          <pub-id pub-id-type="pmid">29491473</pub-id>
        </element-citation>
      </ref>
      <ref id="bib33">
        <label>33</label>
        <element-citation publication-type="journal" id="sref33">
          <person-group person-group-type="author">
            <name>
              <surname>Baker</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Gordon</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Melland</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Bumbak</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Scott</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Owen</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Boyd</surname>
              <given-names>S.G.</given-names>
            </name>
            <name>
              <surname>Rossi</surname>
              <given-names>M.</given-names>
            </name>
            <collab>Broad Center for Mendelian Genomics</collab>
          </person-group>
          <article-title>SYT1-associated neurodevelopmental disorder: A case series</article-title>
          <source>Brain</source>
          <volume>141</volume>
          <year>2018</year>
          <fpage>2576</fpage>
          <lpage>2591</lpage>
          <pub-id pub-id-type="pmid">30107533</pub-id>
        </element-citation>
      </ref>
      <ref id="bib34">
        <label>34</label>
        <element-citation publication-type="journal" id="sref34">
          <person-group person-group-type="author">
            <name>
              <surname>Baker</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Gordon</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Grozeva</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>van Kogelenberg</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>N.Y.</given-names>
            </name>
            <name>
              <surname>Pike</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Blair</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Hurles</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Chong</surname>
              <given-names>W.K.</given-names>
            </name>
            <name>
              <surname>Baldeweg</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling</article-title>
          <source>J.&#xA0;Clin. Invest.</source>
          <volume>125</volume>
          <year>2015</year>
          <fpage>1670</fpage>
          <lpage>1678</lpage>
          <pub-id pub-id-type="pmid">25705886</pub-id>
        </element-citation>
      </ref>
      <ref id="bib35">
        <label>35</label>
        <element-citation publication-type="journal" id="sref35">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>D.H.</given-names>
            </name>
            <name>
              <surname>Matsushita</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Rainier</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Meaney</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Tisch</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Feleke</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wolff</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lipe</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Fink</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Bird</surname>
              <given-names>T.D.</given-names>
            </name>
            <name>
              <surname>Raskind</surname>
              <given-names>W.H.</given-names>
            </name>
          </person-group>
          <article-title>Presence of alanine-to-valine substitutions in myofibrillogenesis regulator 1 in paroxysmal nonkinesigenic dyskinesia: confirmation in 2 kindreds</article-title>
          <source>Arch. Neurol.</source>
          <volume>62</volume>
          <year>2005</year>
          <fpage>597</fpage>
          <lpage>600</lpage>
          <pub-id pub-id-type="pmid">15824259</pub-id>
        </element-citation>
      </ref>
      <ref id="bib36">
        <label>36</label>
        <element-citation publication-type="journal" id="sref36">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>W.J.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Xiong</surname>
              <given-names>Z.Q.</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Ni</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>G.H.</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>Y.F.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Q.J.</given-names>
            </name>
          </person-group>
          <article-title>Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia</article-title>
          <source>Nat. Genet.</source>
          <volume>43</volume>
          <year>2011</year>
          <fpage>1252</fpage>
          <lpage>1255</lpage>
          <pub-id pub-id-type="pmid">22101681</pub-id>
        </element-citation>
      </ref>
      <ref id="bib37">
        <label>37</label>
        <element-citation publication-type="journal" id="sref37">
          <person-group person-group-type="author">
            <name>
              <surname>Lipstein</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Verhoeven-Duif</surname>
              <given-names>N.M.</given-names>
            </name>
            <name>
              <surname>Michelassi</surname>
              <given-names>F.E.</given-names>
            </name>
            <name>
              <surname>Calloway</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>van Hasselt</surname>
              <given-names>P.M.</given-names>
            </name>
            <name>
              <surname>Pienkowska</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>van Haaften</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>van Haelst</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>van Empelen</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Cuppen</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder</article-title>
          <source>J.&#xA0;Clin. Invest.</source>
          <volume>127</volume>
          <year>2017</year>
          <fpage>1005</fpage>
          <lpage>1018</lpage>
          <pub-id pub-id-type="pmid">28192369</pub-id>
        </element-citation>
      </ref>
      <ref id="bib38">
        <label>38</label>
        <element-citation publication-type="journal" id="sref38">
          <person-group person-group-type="author">
            <name>
              <surname>Saitsu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mizuguchi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hamada</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Osaka</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Tohyama</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Uruno</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kumada</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Nishiyama</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Nishimura</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy</article-title>
          <source>Nat. Genet.</source>
          <volume>40</volume>
          <year>2008</year>
          <fpage>782</fpage>
          <lpage>788</lpage>
          <pub-id pub-id-type="pmid">18469812</pub-id>
        </element-citation>
      </ref>
      <ref id="bib39">
        <label>39</label>
        <element-citation publication-type="journal" id="sref39">
          <person-group person-group-type="author">
            <name>
              <surname>Stamberger</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Nikanorova</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Willemsen</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Accorsi</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Angriman</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Baier</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Benkel-Herrenbrueck</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Benoit</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Budetta</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Caliebe</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>STXBP1 encephalopathy: A neurodevelopmental disorder including epilepsy</article-title>
          <source>Neurology</source>
          <volume>86</volume>
          <year>2016</year>
          <fpage>954</fpage>
          <lpage>962</lpage>
          <pub-id pub-id-type="pmid">26865513</pub-id>
        </element-citation>
      </ref>
      <ref id="bib40">
        <label>40</label>
        <element-citation publication-type="journal" id="sref40">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sugiura</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>The role of synaptobrevin1/VAMP1 in Ca2+-triggered neurotransmitter release at the mouse neuromuscular junction</article-title>
          <source>J.&#xA0;Physiol.</source>
          <volume>589</volume>
          <year>2011</year>
          <fpage>1603</fpage>
          <lpage>1618</lpage>
          <pub-id pub-id-type="pmid">21282288</pub-id>
        </element-citation>
      </ref>
      <ref id="bib41">
        <label>41</label>
        <element-citation publication-type="journal" id="sref41">
          <person-group person-group-type="author">
            <name>
              <surname>Bourassa</surname>
              <given-names>C.V.</given-names>
            </name>
            <name>
              <surname>Meijer</surname>
              <given-names>I.A.</given-names>
            </name>
            <name>
              <surname>Merner</surname>
              <given-names>N.D.</given-names>
            </name>
            <name>
              <surname>Grewal</surname>
              <given-names>K.K.</given-names>
            </name>
            <name>
              <surname>Stefanelli</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Hodgkinson</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ives</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Pryse-Phillips</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Jog</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Boycott</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>VAMP1 mutation causes dominant hereditary spastic ataxia in Newfoundland families</article-title>
          <source>Am. J. Hum. Genet.</source>
          <volume>91</volume>
          <year>2012</year>
          <fpage>548</fpage>
          <lpage>552</lpage>
          <pub-id pub-id-type="pmid">22958904</pub-id>
        </element-citation>
      </ref>
      <ref id="bib42">
        <label>42</label>
        <element-citation publication-type="journal" id="sref42">
          <person-group person-group-type="author">
            <name>
              <surname>Salpietro</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Delle Vedove</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Storbeck</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Efthymiou</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Manole</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wiethoff</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Saggar</surname>
              <given-names>A.</given-names>
            </name>
            <collab>SYNAPS Study Group</collab>
          </person-group>
          <article-title>Homozygous mutations in VAMP1 cause a presynaptic congenital myasthenic syndrome</article-title>
          <source>Ann. Neurol.</source>
          <volume>81</volume>
          <year>2017</year>
          <fpage>597</fpage>
          <lpage>603</lpage>
          <pub-id pub-id-type="pmid">28253535</pub-id>
        </element-citation>
      </ref>
      <ref id="bib43">
        <label>43</label>
        <element-citation publication-type="journal" id="sref43">
          <person-group person-group-type="author">
            <name>
              <surname>Shen</surname>
              <given-names>X.M.</given-names>
            </name>
            <name>
              <surname>Scola</surname>
              <given-names>R.H.</given-names>
            </name>
            <name>
              <surname>Lorenzoni</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Kay</surname>
              <given-names>C.S.</given-names>
            </name>
            <name>
              <surname>Werneck</surname>
              <given-names>L.C.</given-names>
            </name>
            <name>
              <surname>Brengman</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Selcen</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Engel</surname>
              <given-names>A.G.</given-names>
            </name>
          </person-group>
          <article-title>Novel synaptobrevin-1 mutation causes fatal congenital myasthenic syndrome</article-title>
          <source>Ann. Clin. Transl. Neurol.</source>
          <volume>4</volume>
          <year>2017</year>
          <fpage>130</fpage>
          <lpage>138</lpage>
          <pub-id pub-id-type="pmid">28168212</pub-id>
        </element-citation>
      </ref>
      <ref id="bib44">
        <label>44</label>
        <element-citation publication-type="journal" id="sref44">
          <person-group person-group-type="author">
            <name>
              <surname>Monies</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Abouelhoda</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>AlSayed</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Alhassnan</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Alotaibi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kayyali</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Al-Owain</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Rahbeeni</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Al-Muhaizea</surname>
              <given-names>M.A.</given-names>
            </name>
          </person-group>
          <article-title>The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes</article-title>
          <source>Hum. Genet.</source>
          <volume>136</volume>
          <year>2017</year>
          <fpage>921</fpage>
          <lpage>939</lpage>
          <pub-id pub-id-type="pmid">28600779</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="app1">
      <title>Accession Numbers</title>
      <p id="p0170">The accession numbers for the DNA sequences reported in this paper are in the Leiden Open Variation Database: 00181522, 00181523, 00181524, 00181525, 00181526.</p>
    </sec>
    <sec id="app4">
      <title>Web Resources</title>
      <p id="p0185">
        <list list-type="simple" id="ulist0015">
          <list-item id="u0035">
            <p id="p0190">CADD, <ext-link ext-link-type="uri" xlink:href="https://cadd.gs.washington.edu/" id="intref0050">https://cadd.gs.washington.edu/</ext-link></p>
          </list-item>
          <list-item id="u0040">
            <p id="p0195">ClustalX, <ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/Tools/msa/clustalw2/" id="intref0055">https://www.ebi.ac.uk/Tools/msa/clustalw2/</ext-link></p>
          </list-item>
          <list-item id="u0045">
            <p id="p0200">Ensembl, <ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/" id="intref0060">http://www.ensembl.org/</ext-link></p>
          </list-item>
          <list-item id="u0050">
            <p id="p0205">Exome Aggregation Consortium (ExAC), <ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org" id="intref0065">http://exac.broadinstitute.org</ext-link></p>
          </list-item>
          <list-item id="u0055">
            <p id="p0210">Exome Variant Server, <ext-link ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/" id="intref0070">http://evs.gs.washington.edu/</ext-link></p>
          </list-item>
          <list-item id="u0060">
            <p id="p0215">Exome Variant Server of the National Heart, Lung, and Blood Institute Grand Opportunity (NHLBI GO) Exome Sequencing Project (accessed February 2014), <ext-link ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/EVS/" id="intref0075">http://evs.gs.washington.edu/EVS/</ext-link></p>
          </list-item>
          <list-item id="u0065">
            <p id="p0220">Genome Analysis Toolkit (GATK), <ext-link ext-link-type="uri" xlink:href="https://www.broadinstitute.org/gatk/" id="intref0080">https://www.broadinstitute.org/gatk/</ext-link></p>
          </list-item>
          <list-item id="u0070">
            <p id="p0225">GenotypeTissue Expression (GTEx) Project, <ext-link ext-link-type="uri" xlink:href="http://www.gtexportal.org" id="intref0085">http://www.gtexportal.org</ext-link></p>
          </list-item>
          <list-item id="u0075">
            <p id="p0230">GnomAD, <ext-link ext-link-type="uri" xlink:href="https://gnomad.broadinstitute.org/" id="intref0090">https://gnomad.broadinstitute.org/</ext-link></p>
          </list-item>
          <list-item id="u0080">
            <p id="p0235">GTEx, <ext-link ext-link-type="uri" xlink:href="http://www.gtexportal.org/home/" id="intref0095">http://www.gtexportal.org/home/</ext-link></p>
          </list-item>
          <list-item id="u0085">
            <p id="p0240">Interactive bio-software, <ext-link ext-link-type="uri" xlink:href="https://www.interactive-biosoftware.com/doc/alamut-visual" id="intref0100">https://www.interactive-biosoftware.com/doc/alamut-visual</ext-link></p>
          </list-item>
          <list-item id="u0090">
            <p id="p0245">NCBI ClinVar database, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/" id="intref0105">https://www.ncbi.nlm.nih.gov/clinvar/</ext-link></p>
          </list-item>
          <list-item id="u0095">
            <p id="p0250">Online Mendelian Inheritance in Man (OMIM), <ext-link ext-link-type="uri" xlink:href="http://omim.org/" id="intref0110">http://omim.org/</ext-link></p>
          </list-item>
          <list-item id="u0100">
            <p id="p0255">Picard, <ext-link ext-link-type="uri" xlink:href="http://broadinstitute.github.io/picard/" id="intref0115">http://broadinstitute.github.io/picard/</ext-link></p>
          </list-item>
          <list-item id="u0105">
            <p id="p0260">Primer-BLAST, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/tools/primer-blast/" id="intref0120">https://www.ncbi.nlm.nih.gov/tools/primer-blast/</ext-link></p>
          </list-item>
          <list-item id="u0110">
            <p id="p0265">UCSC Genome Browser, <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/" id="intref0125">http://genome.ucsc.edu/</ext-link></p>
          </list-item>
          <list-item id="u0115">
            <p id="p0270">UniProt database, <ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/" id="intref0130">https://www.uniprot.org/</ext-link></p>
          </list-item>
        </list>
      </p>
    </sec>
    <sec id="app3" sec-type="supplementary-material">
      <title>Supplemental Data</title>
      <p id="p0180">
        <supplementary-material content-type="local-data" id="mmc1">
          <caption>
            <title>Document S1</title>
            <p>Supplemental Recruitment and Diagnosis, Supplemental Case Reports, Figures S1&#x2013;S6, Table S1, Supplemental Methods, Functional Analyses, Consortia and Networks, and Supplemental References</p>
          </caption>
          <media xlink:href="mmc1.pdf"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="mmc7">
          <caption>
            <title>Document S2. Article plus Supplemental Data</title>
          </caption>
          <media xlink:href="mmc7.pdf"/>
        </supplementary-material>
      </p>
    </sec>
    <ack id="ack0010">
      <title>Acknowledgments</title>
      <p>We gratefully acknowledge all the families for their enthusiastic participation in this study. This study was supported by the <funding-source id="gs1">Wellcome Trust</funding-source> (WT093205MA, WT104033AIA); the <funding-source id="gs2">Medical Research Council</funding-source> (H.H. and D.M.K.); the <funding-source id="gs3">European Community's Seventh Framework&#xA0;Programme</funding-source> (FP7/2007-2013, under grant agreement No. 2012-305121 to H.H.); the <funding-source id="gs4">Italian CINECA Awards</funding-source> (HP10CRVL7F, 2017), which made available high-performance computing resources and provided support; the Spanish Instituto de Salud Carlos III (<funding-source id="gs5">ISCIII</funding-source>) (PI15/01791 A.M.); and the European Regional Development Fund (<funding-source id="gs6">ERDF</funding-source>) (PI17/00487 to F.M-A.). We are also supported by the <funding-source id="gs7">National Institute for Health Research (NIHR)</funding-source>, the <funding-source id="gs8">University College London Hospitals (UCLH)</funding-source>, and the <funding-source id="gs9">Biomedical Research Center (BRC)</funding-source>.</p>
    </ack>
    <fn-group>
      <fn id="app2" fn-type="supplementary-material">
        <p id="p0175">Supplemental Data can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ajhg.2019.02.016" id="intref0045">https://doi.org/10.1016/j.ajhg.2019.02.016</ext-link>.</p>
      </fn>
    </fn-group>
  </back>
</article>
</pmc-articleset>